Encompass Health Co. (NYSE:EHC) Shares Acquired by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans raised its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 16.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 888,827 shares of the company's stock after purchasing an additional 128,331 shares during the quarter. Thrivent Financial for Lutherans owned 0.88% of Encompass Health worth $82,083,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB grew its position in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new position in shares of Encompass Health in the 3rd quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC grew its position in shares of Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new position in shares of Encompass Health in the 4th quarter worth approximately $46,000. Finally, V Square Quantitative Management LLC grew its position in shares of Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after acquiring an additional 177 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Remove Ads

Encompass Health Stock Performance

Encompass Health stock traded down $2.11 during mid-day trading on Friday, hitting $97.05. 841,146 shares of the company's stock traded hands, compared to its average volume of 632,431. The firm has a 50 day moving average price of $97.98 and a 200 day moving average price of $97.13. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company has a market cap of $9.77 billion, a PE ratio of 21.76, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a one year low of $76.11 and a one year high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date is Tuesday, April 1st. Encompass Health's dividend payout ratio is presently 15.25%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on EHC shares. William Blair reiterated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Royal Bank of Canada reissued an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp raised their price target on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. StockNews.com raised Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Finally, Barclays raised their price target on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $107.67.

Insider Transactions at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.10% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.